Relapse Prevention Group Therapy in Indonesia Involving Peers via Videoconferencing for Substance Use Disorder: Development and Feasibility Study.

Relapse Prevention Group Therapy in Indonesia Involving Peers via Videoconferencing for Substance Use Disorder: Development and Feasibility Study.

Publication date: Jun 18, 2024

Substance use disorder (SUD) is a major health issue in Indonesia, where several barriers to treatment exist, including inaccessibility to treatment services, stigma, and criminalization of drug issues. Peer involvement and the use of telemedicine to deliver psychotherapy are promising approaches to overcome these barriers. This study aims (1) to describe the development of a new group psychotherapy coprovided by a health care worker and a peer and (2) to evaluate the acceptability, practicality, and preliminary outcomes of the program delivered via videoconferencing in Indonesia. Building upon an established relapse prevention therapy in Japan, we developed a 3-month weekly group therapy module in the Indonesian language. Adjustments were made via focus group discussions with local stakeholders in terms of substance types, understandability, inclusive language, and cultural relevance. A pilot study was conducted to test the new module provided by a peer and a psychiatrist via videoconferencing, termed tele-Indonesia Drug Addiction Relapse Prevention Program (tele-Indo-DARPP), with a pre- and postcontrolled design. We analyzed data from semistructured feedback interviews and outcome measurements, including the number of days using substances and quality of life, and compared the intervention (tele-Indo-DARPP added to treatment as usual [TAU]) and control (TAU only) arms. In total, 8 people diagnosed with SUD participated in the pilot study with a mean age of 37 (SD 12. 8) years. All were men, and 7 (88%) used sedatives as the primary substance. Collectively, they attended 44 of the 48 tele-Indo-DARPP sessions. A total of 3 out of 4 (75%) preferred telemedicine rather than in-person therapy. Positive acceptability and practicality were shown from qualitative feedback, in which the participants who joined the tele-Indo-DARPP reported that they liked the convenience of joining from home and that they were able to open up about personal matters, received helpful advice from peers, and received support from other participants. Providers reported that they feel the module was provider-friendly, and the session was convenient to join without diminishing rapport-building. Meanwhile, troubles with the internet connection and difficulty in comprehending some terminology in the workbook were reported. The intervention arm showed better improvements in psychological health and anxiety symptoms. Group psychotherapy via videoconferencing coprovided by health care workers and peers was acceptable and practical for participants with SUD and service providers in this study. A large-scale study is warranted to examine the effectiveness of the newly developed module in Indonesia.

Open Access PDF

Concepts Keywords
Indonesia cognitive behavioral therapy
Pilot COVID-19
Psychotherapy digital intervention
Videoconferencing drug
Weekly Indonesia
mobile phone
peer involvement
psychotherapy
substance use disorder
substance use disorders
telemedicine

Semantics

Type Source Name
disease MESH Substance Use Disorder
disease IDO quality
disease IDO intervention
drug DRUGBANK Tropicamide
disease VO effectiveness
disease MESH COVID 19
disease VO Gap
drug DRUGBANK Medical Cannabis
drug DRUGBANK Amphetamine
disease IDO country
disease IDO facility
drug DRUGBANK Methadone
disease MESH opiate dependence
drug DRUGBANK Metamfetamine
disease VO frequency
disease VO effective
disease MESH infections
drug DRUGBANK Ethanol
disease VO population
pathway REACTOME Translation
drug DRUGBANK Diamorphine
disease MESH gambling
disease VO device
disease MESH violence
disease MESH Mental Disorders
disease VO organization
disease VO monthly
disease IDO symptom
drug DRUGBANK Trestolone
disease VO time
disease VO protocol
disease MESH Marital status
disease MESH AIDS
disease VO NAP

Original Article

(Visited 3 times, 1 visits today)